The utility of fasting plasma glucose to identify impaired glucose metabolism in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 30, Issue 9, 2014, Pages 664-666

  Vrbikova, Jana ^a   Hill, Martin ^a   Fanta, Michael ^b  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Impaired glucose metabolism; Polycystic ovary syndrome; Screening

Indexed keywords

CHOLESTEROL; GLUCOSE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; AMENORRHEA; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGOMENORRHEA; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BLOOD; COMPLICATION; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; METABOLISM; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; FASTING; FEMALE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HUMANS; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84906271422     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.912265     Document Type: Article

References (13)

1. March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-51.
2. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012; 33: 981-1030.
3. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010; 16: 347-63.
4. Salley KE, Wickham EP, Cheang KI, et al. POSITION STATEMENT: glucose intolerance in polycystic ovary syndrome. A position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007; 92: 4546-56.
5. Barcellos CR, Rocha MP, Hayashida SA, et al. Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol 2007; 51: 601-5.
6. Gagnon C, Baillargeon JP. Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome. CMAJ 2007; 176: 933-8.
7. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women [see comments]. J Clin Endocrinol Metab 1999; 84: 165-9.
8. Veltman-Verhulst SM, Goverde AJ, van Haeften TW, Fauser BC. Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome. Hum Reprod 2013; 28: 2228-34.
9. Vrbikova J, Fanta M, Cibula D, et al. Impaired glucose metabolism in women with polycystic ovary syndrome. Gynecol Obstet Invest 2009; 68: 186-90.
10. Standards of medical care in diabetes. Diabetes Care 2004; 27: S15-35.
11. Azziz R, Marin C, Hoq L, et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 2005; 90: 4650-8.
12. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
13. Norman RJ, Masters L, Milner CR, et al. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001; 16: 1995-8.